BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 36065689)

  • 1. [Clinical Significance of IgG4 Level in Predicting the Activity and Outcome of Phospholipase A2 Receptor-associated Membranous Nephropathy].
    DU YY; Jiang X; Wang WR; Tang XL; Sun Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Aug; 44(4):579-584. PubMed ID: 36065689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of phospholipase A2 receptor and IgG4 in patients with membranous nephropathy.
    Liu L; Chang B; Wu X; Guo Y; Pan Y; Yang L
    Vasc Health Risk Manag; 2018; 14():103-108. PubMed ID: 29881283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological characteristics of M-type phospholipase A2 receptor (PLA2R)-related membranous nephropathy in Japanese.
    Hayashi N; Akiyama S; Okuyama H; Matsui Y; Adachi H; Yamaya H; Maruyama S; Imai E; Matsuo S; Yokoyama H
    Clin Exp Nephrol; 2015 Oct; 19(5):797-803. PubMed ID: 25492250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective Study of Phospholipase A2 Receptor and IgG Subclasses in Glomerular Deposits in Chinese Patients with Membranous Nephropathy.
    Dong HR; Wang YY; Cheng XH; Wang GQ; Sun LJ; Cheng H; Chen YP
    PLoS One; 2016; 11(5):e0156263. PubMed ID: 27223897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and application of an immunoassay for the simultaneous detection of IgG and its subtype IgG4 autoantibodies against M-type phospholipase A2 receptor.
    Li T; Wu Q; Yang X; Zhang Y; Zhou X; Sheng H; Wang Y; Zhang Q; Liu X; Qin Y; Huang B; Wang L; He Q; Hu Z
    Clin Biochem; 2021 Oct; 96():49-55. PubMed ID: 34252448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PLA2R-IgG4 antibody as a predictive biomarker of treatment effectiveness and prognostic evaluation in patients with idiopathic membranous nephropathy: a retrospective study.
    Huang Y; Zhou J; Zhou K; Huang B; Xue J; Zhang X; Liu B; Zhang Z; Zhou L; Cai T; Zhang Y; Hu Z; Wang L; Liu X
    PeerJ; 2022; 10():e14193. PubMed ID: 36248712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Evaluation of Antiphospholipase A2 Receptor IgG4 level and Its IgG4-to-IgG Ratio Based on Quantitative Immunoassays in Idiopathic Membranous Nephropathy.
    Zhang Y; Huang Y; Huang B; Chen X; Zhou B; Zou P; Wang L; Liu X; Sheng H; Xie M
    Biomed Res Int; 2022; 2022():9127520. PubMed ID: 35782060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cohort study of membranous nephropathy, primary or secondary.
    Arghiani M; Zamani BH; Nazemian F; Samadi S; Afsharian MS; Habibzadeh M; Eslami S; Sabbagh MG
    BMC Nephrol; 2021 Apr; 22(1):138. PubMed ID: 33874909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological characteristics and prognosis of hepatitis B associated membranous nephropathy and idiopathic membranous nephropathy complicated with hepatitis B virus infection.
    Wang R; Wu Y; Zheng B; Zhang X; An D; Guo N; Wang J; Guo Y; Tang L
    Sci Rep; 2021 Sep; 11(1):18407. PubMed ID: 34526634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of the domain specific PLA2R antibodies for clinical remission in patients with primary membranous nephropathy: A retrospective study.
    Zhou K; Zhou J; Zhou L; Xue J; Liu B; Zhang Z; Zhang X; Cai T; Shao S; Huang B; Zhang Y; Hu Z; Wang L; Liu X
    PLoS One; 2024; 19(5):e0302100. PubMed ID: 38718066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative detection and prognostic value of antibodies against M-type phospholipase A2 receptor and its cysteine-rich ricin domain and C-type lectin domains 1 and 6-7-8 in patients with idiopathic membranous nephropathy.
    Liu X; Xue J; Li T; Wu Q; Sheng H; Yang X; Lin B; Zhou X; Qin Y; Huang Z; Zhou L; Wang L; Hu Z; Huang B
    PLoS One; 2024; 19(2):e0298269. PubMed ID: 38386672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative anti-phospholipase A2 receptor antibody status at three months predicts remission in primary membranous nephropathy.
    Stefan G; Stancu S; Zugravu A; Popa O; Zubidat D; Petre N; Mircescu G
    Ren Fail; 2022 Dec; 44(1):258-268. PubMed ID: 35172682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of M
    Gong Z; Yuan S; Zhu X; Wang Y; Yu F; Yang D; Xu X; Liu H; Li J; Sun L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jun; 45(6):693-700. PubMed ID: 32879127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of phospholipase A
    Yeter HH; Isik Gonul I; Eraslan E; Karacalik C; Ogut B; Guz G
    Clin Exp Nephrol; 2021 May; 25(5):488-500. PubMed ID: 33459908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A PLA2R-IgG4 Antibody-Based Predictive Model for Assessing Risk Stratification of Idiopathic Membranous Nephropathy.
    Liu X; Xue J; Guo X; Ding Y; Zhang Y; Zhang X; Huang Y; Huang B; Hu Z; Lu G; Wang L
    J Healthc Eng; 2021; 2021():1521013. PubMed ID: 34512932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic value of renal phospholipase A2 receptor and serum anti-phospholipase A2 receptor antibody in membranous nephropathy].
    Wu X; Wen S; Zhu X; Yuan S; Xu X; Yang D; Sun L; Liu H; Liu F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Apr; 42(4):395-399. PubMed ID: 28490696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Glomerular IgG Subclasses Switch in Idiopathic Membranous Nephropathy Classified by Glomerular Phospholipase A2 Receptor Antigen and Serum Antibody.
    Cui HY; Li C; Li H; Wen YB; Duan L; Li Y; Yan XW; Hu YT; Chen LM; Li XM
    Dis Markers; 2021; 2021():9965343. PubMed ID: 34497677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal expression of PLA2R, THSD7A, and IgG4 in patients with membranous nephropathy and correlation with clinical findings.
    Kaya B; Paydas S; Balal M; Eren Erdogan K; Gonlusen G
    Int J Clin Pract; 2021 Apr; 75(4):e13855. PubMed ID: 33249733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain.
    L'Imperio V; Pieruzzi F; Sinico RA; Nebuloni M; Granata A; Smith A; Radice A; Pagni F
    J Nephrol; 2018 Aug; 31(4):543-550. PubMed ID: 29626294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of serum mannose-binding lectin, anti-phospholipase A2 receptor antibody and renal outcomes in idiopathic membranous nephropathy and atypical membranous nephropathy: a single center retrospective cohort study.
    Zhao Y; Cai M; Jiang Z; Dong B; Yan Y; Wang Y; Zuo L
    Ren Fail; 2022 Dec; 44(1):428-433. PubMed ID: 35272568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.